1. Home
  2. TIMB vs LEGN Comparison

TIMB vs LEGN Comparison

Compare TIMB & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TIM S.A. (Each representing 5)

TIMB

TIM S.A. (Each representing 5)

HOLD

Current Price

$22.00

Market Cap

9.9B

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$23.57

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TIMB
LEGN
Founded
1998
2014
Country
Brazil
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
5.9B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
TIMB
LEGN
Price
$22.00
$23.57
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$25.10
$61.33
AVG Volume (30 Days)
382.5K
2.2M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
4.88%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.47
$42.68
Revenue Next Year
$4.80
$30.52
P/E Ratio
$15.81
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.65
$16.24
52 Week High
$28.22
$44.78

Technical Indicators

Market Signals
Indicator
TIMB
LEGN
Relative Strength Index (RSI) 48.92 35.90
Support Level $21.69 $22.40
Resistance Level $22.58 $23.68
Average True Range (ATR) 0.41 1.27
MACD 0.07 -0.41
Stochastic Oscillator 47.48 18.00

Price Performance

Historical Comparison
TIMB
LEGN

About TIMB TIM S.A. (Each representing 5)

TIM, which is 67%-owned by Telecom Italia, is the third-largest wireless carrier in Brazil, with 62 million subscribers, equal to about 23% of the market. The firm owns 49% of I-Systems, an infrastructure partnership that is expanding its network footprint across Brazil. I-Systems can provide broadband service to about 8 million locations, including 6.5 million with fiber, equal to 10%-15% of the country. TIM leases capacity on the venture's network to serve retail broadband customers under the UltraFibra brand, but it has agreed to buy out its joint venture partner in 2026 and will take full ownership of these assets. TIM also resells fiber network access from other providers.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: